David E I Pyott
Director at Alnylam Pharmaceuticals, Inc. (ALNY)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $1.1M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jun 3SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell Plan | 9214,491 held (−17%) | $297.71 | $274K | -21.8% |
| Jun 3SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell Plan | 1,1753,316 held (−26%) | $298.91 | $351K | -22.2% |
| Jun 3SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell Plan | 1,2222,094 held (−37%) | $299.87 | $366K | -22.4% |
| Jun 3SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell Plan | 4951,599 held (−24%) | $300.72 | $149K | -22.6% |
| Jun 3SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell Plan | 171,582 held (−1%) | $302.65 | $5K | -23.1% |
- Sell
Director David E I Pyott sold $274K of ALNY at $297.71 — pre-scheduled 10b5-1 plan sale.
- Sell
Director David E I Pyott sold $351K of ALNY at $298.91 — cuts the stake by 26%; pre-scheduled 10b5-1 plan sale.
- Sell
Director David E I Pyott sold $366K of ALNY at $299.87 — cuts the stake by 37%; pre-scheduled 10b5-1 plan sale.
- Sell
Director David E I Pyott sold $149K of ALNY at $300.72 — pre-scheduled 10b5-1 plan sale.
- Sell
Director David E I Pyott sold $5K of ALNY at $302.65 — pre-scheduled 10b5-1 plan sale.